Guidance for Cardium Therapeutics, Inc. (CXM)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2026 $0.43 – $0.44 $0.43 $853.00M – 854.00M $838.00M = Maintained Details
2026 $0.39 – $0.40 $0.38 $825.00M – 827.00M $819.90M = Maintained Details
2026 $0.38 – $0.39 $0.38 $821.50M – 823.50M $819.70M = Maintained Details
Q2 2026 $0.10 $0.10 $205.00M – 206.00M $202.80M = Maintained Details
Q1 2026 $0.10 $0.08 $201.50M – 202.50M $200.40M = Maintained Details
2025 $0.31 – $0.32 $0.33 $715.90M – 716.90M $786.00M = Maintained Details
2025 $0.32 – $0.33 $0.41 $785.00M – 787.00M $780.40M = Maintained Details
2025 $0.38 – $0.39 $0.39 $804.50M – 805.50M $802.10M = Maintained Details
Q3 2025 $0.08 $0.12 $196.00M – 197.00M $193.80M = Maintained Details
Q2 2025 $0.06 – $0.07 $0.09 $194.00M – 196.00M $196.90M = Maintained Details
Q1 2025 $0.07 $0.09 $194.00M – 195.00M $193.30M = Maintained Details
2024 $0.36 – $0.37 $0.30 $725.50M – 727.50M $720.50M = Maintained Details
2024 $0.19 – $0.21 $0.14 $711.00M – 715.00M $712.30M = Maintained Details
2024 $0.13 – $0.15 $0.10 $710.00M – 714.00M $710.25M = Maintained Details
Q4 2024 $0.08 – $0.09 $0.08 $187.50M – 189.50M $188.30M = Maintained Details
Q2 2024 $0.04 – $0.05 $0.03 $172.00M – 174.00M $173.20M = Maintained Details
Q1 2024 $0.00 – $0.01 $0.02 $168.00M – 170.00M $168.87M = Maintained Details
2023 ($0.04) – ($0.05) ($0.07) $615.20M – 616.20M $618.00M = Maintained Details
Q4 2023 $0.01 – $0.02 $0.01 $162.30M – 163.30M $166.10M = Maintained Details
2022 N/A N/A $612.00M – 618.00M $611.00M = Maintained Details
2022 $0.20 – $0.22 ($0.20) $536.00M – 544.00M $588.00M = Maintained Details
Q2 2022 N/A N/A $146.50M – 148.50M $147.30M = Maintained Details
2021 ($0.08) – ($0.09) $0.09 $129.00M – 131.00M $128.30M = Maintained Details